Old Web
English
Sign In
Acemap
>
authorDetail
>
Shepard Mpofu
Shepard Mpofu
Novartis
Medicine
Secukinumab
signs and symptoms
Management
Virology
5
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
255 Secukinumab provides rapid and sustained resolution of enthesitis in psoriatic arthritis patients: pooled analysis of two Phase 3 studies, FUTURE 2 and FUTURE 3
2019
Rheumatology
Laura C. Coates
Dennis McGonagle
Georg Schett
Philip J. Mease
Erhard Quebe-Fehling
Darren L Asquith
Lawrence Rasouliyan
Shepard Mpofu
Corine Gaillez
Show All
Source
Cite
Save
Citations (0)
Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial
2017
Philip J. Mease
Arthur Kavanaugh
Andreas M. Reimold
Hasan Tahir
Juergen Rech
Stephen Hall
Piet P.M.M. Geusens
Pellet Pascale
Evie Marie Delicha
Luminata Pricop
Shepard Mpofu
Show All
Source
Cite
Save
Citations (1)
Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial
2017
Philip J. Mease
A. Kavanaugh
Andreas M. Reimold
Hasan Tahir
Juergen Rech
Stephen B. Hall
Piet Geusens
Pellet Pascale
Evie Marie Delicha
Luminata Pricop
Shepard Mpofu
Show All
Source
Cite
Save
Citations (2)
Verfahren zur behandlung von spondylitis ankylosans oder psoriasisarthritis mit anti-il-17 antikörpern
2011
Shepard Mpofu
H. Richards
Karthinathan Thangavelu
Matthias Machacek
Show All
Source
Cite
Save
Citations (0)
Méthodes de traitement de la spondylarthrite ankylosante ou du rhumatisme psoriasique au moyen d'anticorps anti-il-17
2011
Shepard Mpofu
H. Richards
Karthinathan Thangavelu
Matthias Machacek
Show All
Source
Cite
Save
Citations (0)
1